Stay updated on L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Sign up to get notified when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.

Latest updates to the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial record for the Latanoprost punctal plug delivery system is now displayed, with study details for a completed Phase 2 trial and no longer-recruiting status. It includes participant criteria, six study locations, the treatment plan, outcome measures, and record history.SummaryDifference34%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer version changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedAn NIH announcement banner was added, notifying visitors about a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error instead of displaying the study record.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record details, indicating an access restriction rather than a change to the study information.SummaryDifference15%

Stay in the know with updates to L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.